| Dr Saadi Ahmad Siddiqi, DO | |
|
80 Vermont Ave, Oak Ridge, TN 37830-6474 | |
| (865) 482-4078 | |
| (865) 482-4960 |
| Full Name | Dr Saadi Ahmad Siddiqi |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 22 Years |
| Location | 80 Vermont Ave, Oak Ridge, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396944575 | NPI | - | NPPES |
| Q004089 | Medicaid | TN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0011X | Internal Medicine - Interventional Cardiology | 2582 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Methodist Medical Center Of Oak Ridge | Oak ridge, TN | Hospital |
| Roane Medical Center | Harriman, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Covenant Medical Group Inc | 2860305463 | 282 |
| Methodist Medical Center | 7012812860 | 10 |
| Roane County Medical Center | 8921167545 | 6 |
News Archive
As the population ages and demography changes, the UK is facing an unprecedented challenge of how to care for and support its older people.
Orexigen Therapeutics, Inc. today announced data from the CORDiabetes trial for Contrave (naltrexone sustained release (SR)/bupropion SR) showing that after 56 weeks of treatment, overweight or obese patients with type 2 diabetes lost significantly more weight and achieved greater improvement in glycemic control than those treated with placebo.
Translational Genomics Research Institute (TGen) scientists have identified five genetic biomarkers that could help lead to improved treatments, with fewer side-effects, for patients with diabetes.
The sixth annual Consortium of Universities for Global Health conference is creating a stir by bringing together some of the world's leading researchers to tackle many of the biggest global health challenges we face.
Climate change may keep you awake - and not just metaphorically. Nights that are warmer than normal can harm human sleep, researchers show in a new paper, with the poor and elderly most affected.
› Verified 5 days ago
| Entity Name | Parkwest Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396739165 PECOS PAC ID: 8527965417 Enrollment ID: O20040429000423 |
News Archive
As the population ages and demography changes, the UK is facing an unprecedented challenge of how to care for and support its older people.
Orexigen Therapeutics, Inc. today announced data from the CORDiabetes trial for Contrave (naltrexone sustained release (SR)/bupropion SR) showing that after 56 weeks of treatment, overweight or obese patients with type 2 diabetes lost significantly more weight and achieved greater improvement in glycemic control than those treated with placebo.
Translational Genomics Research Institute (TGen) scientists have identified five genetic biomarkers that could help lead to improved treatments, with fewer side-effects, for patients with diabetes.
The sixth annual Consortium of Universities for Global Health conference is creating a stir by bringing together some of the world's leading researchers to tackle many of the biggest global health challenges we face.
Climate change may keep you awake - and not just metaphorically. Nights that are warmer than normal can harm human sleep, researchers show in a new paper, with the poor and elderly most affected.
› Verified 5 days ago
| Entity Name | Fort Sanders Regional Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942294814 PECOS PAC ID: 9537066428 Enrollment ID: O20040429000650 |
News Archive
As the population ages and demography changes, the UK is facing an unprecedented challenge of how to care for and support its older people.
Orexigen Therapeutics, Inc. today announced data from the CORDiabetes trial for Contrave (naltrexone sustained release (SR)/bupropion SR) showing that after 56 weeks of treatment, overweight or obese patients with type 2 diabetes lost significantly more weight and achieved greater improvement in glycemic control than those treated with placebo.
Translational Genomics Research Institute (TGen) scientists have identified five genetic biomarkers that could help lead to improved treatments, with fewer side-effects, for patients with diabetes.
The sixth annual Consortium of Universities for Global Health conference is creating a stir by bringing together some of the world's leading researchers to tackle many of the biggest global health challenges we face.
Climate change may keep you awake - and not just metaphorically. Nights that are warmer than normal can harm human sleep, researchers show in a new paper, with the poor and elderly most affected.
› Verified 5 days ago
| Entity Name | Methodist Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700870672 PECOS PAC ID: 7012812860 Enrollment ID: O20050131000095 |
News Archive
As the population ages and demography changes, the UK is facing an unprecedented challenge of how to care for and support its older people.
Orexigen Therapeutics, Inc. today announced data from the CORDiabetes trial for Contrave (naltrexone sustained release (SR)/bupropion SR) showing that after 56 weeks of treatment, overweight or obese patients with type 2 diabetes lost significantly more weight and achieved greater improvement in glycemic control than those treated with placebo.
Translational Genomics Research Institute (TGen) scientists have identified five genetic biomarkers that could help lead to improved treatments, with fewer side-effects, for patients with diabetes.
The sixth annual Consortium of Universities for Global Health conference is creating a stir by bringing together some of the world's leading researchers to tackle many of the biggest global health challenges we face.
Climate change may keep you awake - and not just metaphorically. Nights that are warmer than normal can harm human sleep, researchers show in a new paper, with the poor and elderly most affected.
› Verified 5 days ago
| Entity Name | Covenant Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457302010 PECOS PAC ID: 2860305463 Enrollment ID: O20060719000030 |
News Archive
As the population ages and demography changes, the UK is facing an unprecedented challenge of how to care for and support its older people.
Orexigen Therapeutics, Inc. today announced data from the CORDiabetes trial for Contrave (naltrexone sustained release (SR)/bupropion SR) showing that after 56 weeks of treatment, overweight or obese patients with type 2 diabetes lost significantly more weight and achieved greater improvement in glycemic control than those treated with placebo.
Translational Genomics Research Institute (TGen) scientists have identified five genetic biomarkers that could help lead to improved treatments, with fewer side-effects, for patients with diabetes.
The sixth annual Consortium of Universities for Global Health conference is creating a stir by bringing together some of the world's leading researchers to tackle many of the biggest global health challenges we face.
Climate change may keep you awake - and not just metaphorically. Nights that are warmer than normal can harm human sleep, researchers show in a new paper, with the poor and elderly most affected.
› Verified 5 days ago
| Entity Name | Roane County Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821274481 PECOS PAC ID: 8921167545 Enrollment ID: O20090725000014 |
News Archive
As the population ages and demography changes, the UK is facing an unprecedented challenge of how to care for and support its older people.
Orexigen Therapeutics, Inc. today announced data from the CORDiabetes trial for Contrave (naltrexone sustained release (SR)/bupropion SR) showing that after 56 weeks of treatment, overweight or obese patients with type 2 diabetes lost significantly more weight and achieved greater improvement in glycemic control than those treated with placebo.
Translational Genomics Research Institute (TGen) scientists have identified five genetic biomarkers that could help lead to improved treatments, with fewer side-effects, for patients with diabetes.
The sixth annual Consortium of Universities for Global Health conference is creating a stir by bringing together some of the world's leading researchers to tackle many of the biggest global health challenges we face.
Climate change may keep you awake - and not just metaphorically. Nights that are warmer than normal can harm human sleep, researchers show in a new paper, with the poor and elderly most affected.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Saadi Ahmad Siddiqi, DO 80 Vermont Ave, Oak Ridge, TN 37830-6474 Ph: (865) 482-4078 | Dr Saadi Ahmad Siddiqi, DO 80 Vermont Ave, Oak Ridge, TN 37830-6474 Ph: (865) 482-4078 |
News Archive
As the population ages and demography changes, the UK is facing an unprecedented challenge of how to care for and support its older people.
Orexigen Therapeutics, Inc. today announced data from the CORDiabetes trial for Contrave (naltrexone sustained release (SR)/bupropion SR) showing that after 56 weeks of treatment, overweight or obese patients with type 2 diabetes lost significantly more weight and achieved greater improvement in glycemic control than those treated with placebo.
Translational Genomics Research Institute (TGen) scientists have identified five genetic biomarkers that could help lead to improved treatments, with fewer side-effects, for patients with diabetes.
The sixth annual Consortium of Universities for Global Health conference is creating a stir by bringing together some of the world's leading researchers to tackle many of the biggest global health challenges we face.
Climate change may keep you awake - and not just metaphorically. Nights that are warmer than normal can harm human sleep, researchers show in a new paper, with the poor and elderly most affected.
› Verified 5 days ago
Chukwuma Umunakwe, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 990 Oak Ridge Tpke, Oak Ridge, TN 37830 Phone: 202-841-5854 | |
Dr. Michael Roger Thompson, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 200 New York Ave, Suite 200, Oak Ridge, TN 37830 Phone: 865-835-5400 Fax: 865-835-5401 | |
Andrew W Dake, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 800 Oak Ridge Turnpike, Suite A-402, Oak Ridge, TN 37830 Phone: 865-637-8812 Fax: 865-824-4886 | |
Aaron Joshua Smyth, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 801 Oak Ridge Tpke, Oak Ridge, TN 37830 Phone: 865-483-3172 Fax: 865-483-8689 | |
Daniel James Gavin, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 990 Oak Ridge Tpke, Oak Ridge, TN 37830 Phone: 865-835-1000 Fax: 865-539-8008 | |
Helen Susan Bidawid, M.D. Internal Medicine Medicare: May Accept Medicare Assignments Practice Location: 990 Oak Ridge Tpke, Oak Ridge, TN 37830 Phone: 865-481-1000 | |
Victor W Mclaughlin, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 80 Vermont Ave, Oak Ridge, TN 37830 Phone: 865-482-4078 Fax: 865-482-4960 |